Eli Lilly and Co News

Eli Lilly and Co | DEFA14A: Others

Mar 22 16:29 ET

Eli Lilly and Co | DEF 14A: Definitive information statements

Mar 22 16:28 ET

Eli Lilly and Co | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Mar 8 16:36 ET

Eli Lilly and Co | 8-K: Entry into an Underwriting Agreement

Feb 9 12:00 ET

Eli Lilly and Co | 8-K: Eli Lilly and Co Reports Fourth Quarter 2023 Financial Results and Provides 2024 Financial Guidance

Feb 6 07:06 ET

Eli Lilly and Co | 8-K: Eli Lilly and Co Reports Third Quarter 2023 Financial Results

Nov 2, 2023 07:02 ET

Eli Lilly and Co | 8-K: Eli Lilly and Co Reports Second-Quarter 2023 Financial Results

Aug 8, 2023 07:01 ET

Eli Lilly and Co | 8-K: Voting results 2023 Annual Meeting of Shareholders

May 4, 2023 16:33 ET

Eli Lilly and Co | 8-K: Eli Lilly and Co Reports First-Quarter 2023 Financial Results

Apr 27, 2023 07:02 ET

Eli Lilly and Co | DEFA14A: Others

Mar 17, 2023 16:26 ET

Eli Lilly and Co | DEF 14A: Definitive proxy statements

Mar 17, 2023 16:21 ET

Eli Lilly and Co | 8-K: Eli Lilly entered into a non-competition agreement with Daniel Skovronsky

Mar 17, 2023 16:05 ET

Eli Lilly and Co | 8-K: Eli Lilly and Co entered into an underwriting agreement

Feb 24, 2023 17:00 ET

Eli Lilly and Co | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition

Feb 24, 2023 16:18 ET

Eli Lilly and Co | 8-K: Lilly Reports Fourth-Quarter 2022 Financial Results, Core Business Growth and Pipeline Advancements Support Strong Long-Term Outlook

Feb 2, 2023 07:13 ET

Eli Lilly and Co | 8-K: Eli Lilly and Co Announces 2023 Financial Guidance and Plans to Launch up to Four New Medicines

Dec 13, 2022 07:03 ET

Eli Lilly and Co | 8-K: Lilly Reports Solid Third-Quarter 2022 Financial Results and Continued Pipeline Progress

Nov 1, 2022 07:03 ET

Eli Lilly and Co | 8-K: Estimated Third Quarter Acquired In-Process Research and Development and Development Milestone Charges

Oct 12, 2022 16:08 ET

Eli Lilly and Co | 8-K: Current report

Aug 4, 2022 07:05 ET

Eli Lilly and Co | 8-K: Current report

May 6, 2022 16:23 ET